# Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00379730** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 90 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT00379730
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03-21
- **Primary completion:** —
- **Final completion:** 2007-05-03
- **Target enrollment:** 90 (—)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379730, "Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00379730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*